CORC  > 昆明医科大学
Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patients
Jia, Jidong/7202343661[0]; Hou, Jinlin/7401966390[1]; Yin, Youkuan/7403273282[2]; Tan, Deming/7202901976[3]; Xu, Daozhen/7404074134[4]; Niu, Junqi/8329820300[5]; Zhou, Xiaqiu/7410092244[6]; Wang, Yuming/8389144000[7]; Zhu, Limin/36645497200[8]; Chen, Chengwei/8071004700[9]
刊名Hepatology International
2014
卷号8期号:1
关键词China Chronic hepatitis B Lamivudine Nucleoside analogs Randomized clinical trial Telbivudine
ISSN号1936-0533
URL标识查看原文
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3442327
专题昆明医科大学
推荐引用方式
GB/T 7714
Jia, Jidong/7202343661[0],Hou, Jinlin/7401966390[1],Yin, Youkuan/7403273282[2],et al. Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patients[J]. Hepatology International,2014,8(1).
APA Jia, Jidong/7202343661[0].,Hou, Jinlin/7401966390[1].,Yin, Youkuan/7403273282[2].,Tan, Deming/7202901976[3].,Xu, Daozhen/7404074134[4].,...&Trylesinski, Aldo/6603116476[18].(2014).Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patients.Hepatology International,8(1).
MLA Jia, Jidong/7202343661[0],et al."Two-year results of a randomized, phase III comparative trial of telbivudine versus lamivudine in Chinese patients".Hepatology International 8.1(2014).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace